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Background
Diffusion tensor imaging (DTI) is an advanced neuroim-
aging technique that characterizes in vivo anisotropic dif-
fusion in the white matter (WM). However, its application
in hydrocephalus patients, especially in those at very
young age, is very limited. The purpose of this study is to
apply DTI to test the abnormality of anisotropic diffusion
properties at various WM regions in hydrocephalic chil-
dren.
Materials and methods
We retrospectively reviewed clinical DTI datasets and
identified three groups of participants. The control group
included 61 patients (Age range = 0.2 – 206.0 months,
Mean ± SD = 110.3 ± 65.3 months) who were scanned for
non-CNS related problems and had no prior record of a
neurological disorder. The pre-shunt hydrocephalus
group included 12 patients (Age range = 0.03 – 78.15
months, Mean ± SD = 8.68 ± 19.06 months) who had
MRI/DTI prior to shunt surgery. The post-shunt hydro-
cephalus group included 19 patients (Age range = 12.76 –
212.65 months, Mean ± SD = 59.97 ± 62.42 months) who
had MRI/DTI after shunt surgery. Fractional anisotropy
(FA) was computed in selected region of interest in corpus
callusom and internal capsule.
Results
Consistent to the published literature, FA values of nor-
mal children in all the ROIs demonstrated a characteristic
exponential pattern during development. In general, the
FA values undergo a very rapid rise during the first 12
months of life. It begins to level off in the second year and
completes by 36 months of age.
In genu of corpus callosum (gCC), only 1/11 patients in
the pre-shunt group had normal FA value while all other
patients 10/11 had abnormally low FA value. On the
other hand, for patients in post-shunt group, 11/18 had
normal FA and only 7/18 had abnormally low FA. The fre-
quency of occurrence of low FA is significantly different (p
= 0.007, Fisher's exact test) in the two groups. In posterior
limb of internal capsule (PLIC), 7/12 had normal FA and
5/12 had abnormally high FA in the pre-shunt group. In
post-shunt group, the percentage of patients with normal
FA (11/19, 58.9%) is similar to the pre-shunt group. How-
ever, the rest of the patients (8/19) all had abnormally low
FA.
Conclusion
This study demonstrated the efficacy of applying DTI in
investigating WM integrity in paediatric hydrocephalic
patients at early childhood. The FA abnormality and its
difference in frequency of occurrence or the direction of
deviation from normal range between the two hydro-
cephalic groups may bear significant implication for the
underlying injury mechanism as well as the reversibility at
various WM regions.
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